Genitourinary syndrome. Menopausal and other perimenopausal disorders
Conditions
Interventions
Intervention 1: First intervention group:PRP recipient In this study, a topical anesthetic cream is used to numb the anterior vaginal wall and clitoris, and the PRP injection is performed 20 minutes a
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 70 Years
Inclusion criteria
Inclusion criteria: Postmenopausal women diagnosed with vaginal atrophy
Exclusion criteria
Exclusion criteria: History of any type of vaginal cancer or previous radiotherapy Current use of vaginal lubricants or moisturizers Use of anabolic steroids, systemic estrogen therapy in the past 6 months Abnormal uterine bleeding Acute thrombophlebitis, or previous thromboembolic disorders related to estrogen use within the past 6 months prior to the study Those who have any contraindications to estrogen therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary tract function. Timepoint: Beginning of the study, weeks 4, 8, and 12. Method of measurement: International consulation on incontinence questionnaire short form and Urogenital distress inventory scale.;Sexual function. Timepoint: Beginning of the study, weeks 4, 8, and 12. Method of measurement: Female sexual function index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParand Eskandari
Yasouj University of Medical Sciences
Outcome results
None listed